Background: A variety of copy number variants are associated with a high risk of
variance explained by genotype was low, 5-20% depending on trait, indicating that overall ND-CNVs lead to similar neurodevelopmental outcomes. It is important that genotype-phenotype relationships are viewed through a developmental lens as some phenotypic outcomes were found to be associated with age.
Implications of all the available evidence
Children who carry a ND-CNV represent a patient group that warrants clinical and educational attention for a broad range of cognitive and behavioural impairments. Although qualitative and quantitative differences exist between ND-CNVs, our findings point to commonalities in clinical outcomes with neurodevelopmental impairments being present across all ND-CNVs. This group of young people could benefit from the development of a general intervention plan, to which genotype-specific recommendations can be added where needed. Our findings do not support a model whereby different ND-CNVs represent discrete forms of neuropsychiatric disorder and suggest that multiple processes and neural circuits are affected by ND-CNVs. The pleiotropic effects of ND-CNVs emphasises that research aiming to identify causal pathways between genetic variation and psychiatric outcomes via intermediary (or endo-)phenotypes needs to take a global perspective and not be narrowly focused on single phenotypes.
Introduction
The advent of microarray technology has heralded a new era for understanding the clinical genetics of neuropsychiatric disorders. A striking finding has been the implication of copy number variants (CNVs) in these disorders 1 , including intellectual disability (ID), autism spectrum disorder (ASD) and schizophrenia [2] [3] [4] . CNVs are submicroscopic deletions or duplications within the genome that are greater than 1000 base pairs 5 and several loci have been identified whereby CNVs recur with sufficient frequency in the population to be associated with neurodevelopmental and psychiatric outcomes (hereafter referred to as ND-CNVs). Recurrent ND-CNVs are individually rare, but collectively pathogenic ND-CNVs have been implicated in ~15% of patients with neurodevelopmental disability 6 . Although these ND-CNVs are strongly associated with disorder, they have incomplete penetrance and exhibit a high degree of pleiotropy, conferring risk for a broad range of psychiatric disorders, cognitive deficits and medical/physical comorbidities across the lifespan [7] [8] [9] [10] .
Current understanding of genotype-phenotype relationships is hampered by a lack of studies that have conducted cross-CNV comparisons 11 . Therefore it is unclear to what extent phenotypic findings for different genotypes can be compared across studies and what the impact is of variation in sample sizes and methodological issues of ascertainment and phenotyping. Increasing use of array screening in the assessment of children with neurodevelopmental delay is leading to a rise in the diagnosis of ND-CNVs by medical genetics clinics, yet information on long-term neuropsychiatric prognosis is lacking. There is a need to understand whether different genotypes are associated with specific neuropsychiatric, cognitive and other phenotypes. We posit four different models of potential genotype-phenotype relationships ( Figure 1 ). 1) The null model proposes that phenotypic profile does not differ between genotypes (Model 1, Figure 1 ). 2) Phenotypic differences are qualitative in nature, whereby each ND-CNV is associated with a distinct phenotype due to the specific genes involved (Model 2, Figure 1 ). 3) Phenotypic differences are quantitative in nature whereby all ND-CNVs impact on the same range of outcomes but differ from each other in magnitude of impairment (Model 3, Figure 1 ). 4) A combination of the Models 2 and 3 best explains differences in phenotypic outcome across ND-CNVs (Model 4, Figure1). There is support for the qualitative differences model in the autism field where it is hypothesised that the disorder is dissociable by the genetic underpinnings 12, 13 , with some researchers usi g the ter autis s
14
. The quantitative differences model is supported by findings that genes across ND-CNVs impact shared pathways leading to outcomes such as cognitive impairment 15 and increased schizophrenia risk 16 , indicating that common mechanisms act across loci. It is important to highlight that variability in phenotypic outcomes will also be shaped by incomplete penetrance 8 , life course developmental stage 17 , genetic context including polygenic risk 18 and additional mutations 19, 20 as well as environmental exposures 21 .
Here we present findings from a cohort of children with ND-CNVs from the IMAGINE-ID (Intellectual Disability & Mental Health: Assessing the Genomic Impact on Neurodevelopment) consortium.
Individuals were recruited on the basis of genotype ia the U ited Ki gdo 's (UK) National Health Service (NHS) medical genetic clinic network. Broad online phenotyping was conducted on over 2500
individuals (results will be reported elsewhere), and deep phenotyping was conducted within a subgroup of the cohort with assessments covering a range of neuropsychiatric, cognitive and other traits using a multi-informant approach. Here we report on findings from the deep phenotyping component of IMAGINE-ID. First, we characterised the impact of recurrent ND-CNVs on child development by contrasting the performance of CNV carriers with sibling controls. Next, we evaluated the phenotypic differences between genotypes and determined whether these were qualitative or quantitative in nature. Finally, we established the extent to which neuropsychiatric, cognitive and other outcomes are affected by gender and age.
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Psychopathology and functioning
The Child and Adolescent Psychiatric Assessment (CAPA) 28 carer report interview was used to derive categorical diagnoses and a total symptom count composite score, as well as the following symptom subscales: attention deficit hyperactivity disorder (ADHD), anxiety, mood, obsessive-compulsive disorder (OCD), oppositional defiant disorder (ODD), and problems with sleep. The child report CAPA was conducted to assess subclinical psychotic experiences. Interviews were taped and diagnoses confirmed in consensus meeting led by a child psychiatrist. General and social functioning was assessed by the psychologists conducting the home visit usi g the Childre 's Glo al Assess e t Scale (CGAS) 29 and the Social and Occupational Functioning Assessment Scale (SOFAS) 30 . Autism
Spectrum Disorder (ASD) traits were assessed via caregiver report using the Social Communication Questionnaire (SCQ) 31 . Motor coordination impairment was assessed via caregiver report using the . CC-BY 4.0 International license It is made available under a (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
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Analysis
Aim 1: Cognitive and behavioural phenotype of ND-CNV carriers in relation to controls
Categorical outcome measures
The prevalence of psychiatric disorder was compared between ND-CNV carriers and controls.
Analysis was conducted using generalized linear mixed-effects models, with carrier status, age and gender as fixed effects and family as a random effect to take into account that control siblings are related to ND-CNV carriers.
Continuous outcome measures
All cognitive and behavioural trait scores and composite scores (FSIQ, PIQ, VIQ, total symptom count and SDQ total score) were tra sfor ed usi g Tukey's Ladder of Powers. This transformation makes the data fit the normal distribution as closely as possible. All tests scores were then standardised into z-scores using the mean and SDs of the control group as reference. Z-scores were constructed so that a negative score denoted a poorer outcome. Linear mixed-effects models were conducted with test score as the outcome and carrier status, age and gender as fixed effects and family as a random effect.
To estimate the standardised difference between ND-CNV carriers and controls Cohe 's d was calculated. To assess the potential effects of intelligence on group differences, analyses were repeated with FSIQ as a covariate. To correct for multiple testing in Aim 1 a Benjamini-Hochberg false discovery rate (B-H FDR) of 0.05 for correction of p-values was applied.
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Analysis of qualitative and quantitative differences in overall phenotypic profile was based on ranking the mean of each phenotypic trait score for each ND-CNV. In the analysis of qualitative effects a set of phenotype rankings was created for each ND-CNV (Model 2, Figure 1 , within each genotype row, phenotype was ranked by phenotypic severity). Rank discordance between ND-CNVs would suggest that the phenotype profile for each ND-CNV differs, therefore indicating the presence of qualitative differences. In the analysis of quantitative effects a set of ND-CNV rankings was created for each phenotype (Model 3, Figure 1 , within each phenotype column, each ND-CNV was ranked by phenotypic severity). Rank concordance between phenotypes would suggest that ND-CNVs differ in se erity a ross phe otypes, therefore i di ati g ua titati e differe es. Note these odels are 't opposing ends of a spectrum, both quantitative and qualitative effects can be present (Model 4, Figure   1 ). To test for similarities and differences for both qualitative and quantitative effects across ND-CNVs, rank concordance was assessed usi g Ke dall's test a d rank discordance using the Friedman test.
This rank concordance based approach has been previously used to investigate genotype-phenotype relationships 34 . To avoid collinearity, composite scores were not included in the concordance analysis.
Furthermore to test for quantitative effects between ND-CNVs at the level of individual traits, ANCOVAs were conducted with the test score as the outcome, genotype as the predictor, and gender and age as covariates. To correct for multiple testing a B-H FDR 0.05 correction of p-values was applied.
Aim 3: Effect of age and gender on cognitive and behavioural outcomes
To investigate the influence of gender and age on the outcomes within ND-CNV carriers, we estimated eta-squared and standardised beta value from the ANCOVAs conducted for the quantitative analysis.
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Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results

Aim 1:
Cognitive and behavioural phenotype of ND-CNV carriers in relation to controls ) and Tic Disorder (16.3% vs 0.0%, p=2.10×10 -5 , OR could not be estimated as no controls affected) compared to controls (see Table 2 ). These results remained significant when FSIQ was controlled for, and all survived B-H FDR correction. Mood disorder, OCD and subclinical psychotic experiences were present in ND-CNV carriers but prevalence was not significantly elevated relative to controls. None of the ND-CNV carriers or controls met criteria for psychotic disorder.
Continuous outcome measures
Linear mixed-effects model analysis found that ND-CNV carriers showed significant impairment on all cognitive and behavioural traits and composite scores (Table 3, Figure 2 ) compared to controls. These results remained significant when FSIQ was controlled for, and all survived B-H FDR correction.
Cohe 's d aried fro . 7 (subclinical psychotic experiences) to 1.76 (hyperactivity subscale, caregiver reported). Large effect size differences between ND-CNV carriers and controls were found for FSIQ, including PIQ, VIQ and all comprising subtests, sustained attention, total psychiatric symptom count, ADHD and ASD traits, motor coordination, general and social functioning, total SDQ score (carer and teacher report) and hyperactivity (carer and teacher report), peer (carer report), prosocial (carer report) SDQ subscales.
As well as caregiver report, teachers reported that ND-CNV carriers scored significantly worse on SDQ total score and subscale scores (Table 3 and Figure 2 ). Teacher reported SDQ scores were moderately correlated with carer report scores; total SDQ score r= 0.470, p=1.35×10 .
In terms of the overall phenotypic profile there was evidence of both qualitative and quantitative differences between genotypes. Both tests of significance for rank concordance and discordance were significant for both analyses of qualitative (Friedman chi-squared = 177. 39 ). These findings indicate that, although significant quantitative and qualitative differences exist, the converse is true in that qualitative and quantitative similarities also exist. We therefore conclude effects for both qualitative as well as quantitative differences between genotypes are moderate, and overall our data supports Model 4 ( Figure 1) . A sensitivity analysis was conducted excluding individuals with 9q34.3 deletion or 22q11.2 deletion as the dendrogram ( Figure   3 ) indicated their phenotypic profiles stood apart from the other ND-CNVs and that this could drive the differences we found. However, excluding these two groups did not change our finding of moderate qualitative and a quantitative differences between genotypes, and did not change the hierarchical clustering of traits into neurodevelopmental traits and mental health and cognitive comorbidities.
At the level of individual phenotypic traits quantitative differences were found with genotype predicting between 5-20% of variance (Eta-squared effect size) in impairment within ND-CNV carriers depending on the specific trait ( Table 4 ). The effect of genotype significantly predicted impairment severity in some traits; FSIQ, PIQ, VIQ, all the IQ subtests, spatial planning, processing speed, total CAPA symptom count including the anxiety, ADHD and ODD subscales, subclinical psychotic experiences, social functioning, ASD traits, motor coordination, SDQ total including conduct, hyperactivity and prosocial subscales (Table 4) . However, for set-shifting ability, spatial working memory, sustained attention, mood CAPA subscale, OCD CAPA subscale, sleep CAPA subscale, general functioning, emotional SDQ subscale, and the peer SDQ subscale, the effect of genotype was not significant. For these analyses, p-values equal or less than 0.02 survived BH-FDR 0.05 correction.
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The phenotypic profile of ND-CNV carriers was influenced by age (accounting for 0-25% of variance depending on trait) with deficits in some traits becoming reduced in older children: the hyperactivity SDQ su s ale (β = . 8, p=5.04×10 
Discussion
The IMAGINE-ID cohort allowed us to conduct one of the largest studies to define genotypephenotype relationships across a range of ND-CNV loci. Overall our findings support a model whereby these ND-CNVs have a broadly general effect on phenotypic outcome, but specific effects can be identified, albeit accounting for a low proportion of variance (5-20% depending on trait). Some traits had similar levels of impairment across all genotypes (e.g. mood problems, sleep impairments, peer problems, and sustained attention) whereas for other traits there was more evidence of genotype specific patterns (e.g., IQ, spatial planning, processing speed, subclinical psychotic experiences, ASD traits, motor coordination total psychiatric symptomatology, particularly anxiety, ADHD, and conduct related traits). Phenotypic differences between ND-CNVs were found to be both quantitative and as well as qualitative in nature (Model 4, Figure 1 ). Hierarchical cluster analysis of phenotypic traits . CC-BY 4.0 International license It is made available under a (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint . http://dx.doi.org/10.1101/535708 doi: bioRxiv preprint first posted online Jan. 31, 2019; identified two clusters; neurodevelopmental traits that were strongly impaired across CNVs, and mental health and cognitive comorbidities where impairment was generally less and more variable across the genotypes. ND-CNVs affect biological pathways that impact risk of developmental impairment and this impairment differs in magnitude by genotype, but the unique gene content of each ND-CNV also appears to mould the specific psychiatric, cognitive and other manifestations. As a group, children with a ND-CNV were found to be at very high risk of developing psychiatric disorder, with 79.8% having at least one psychiatric diagnosis. Moreover, using a broad multi-informant approach we found that ND-CNV carriers were impaired relative to their siblings across all the psychiatric, neurodevelopmental, psychopathological, cognitive, social, sleep and motor domains assessed. This patient group clearly warrants clinical and educational attention and intervention.
ND-CNV carriers were found to be at increased risk for a range of psychiatric disorders (OR=13.8 for any disorder), including ADHD (OR=6.9), anxiety disorder (OR=2.9), ASD (OR=44.1), ODD (OR=43.6), and tic disorders (OR could not be calculated as no controls were affected). All the ND-CNV carriers were impaired across all behavioural and cognitive traits measured, the strongest trait differences found between ND-CNV carriers and controls included ASD symptom count (d=1.71), hyperactivity (d=1.76), social functioning (d=1.60) and motor coordination (d=1.62). Motor coordination is a domain that has been relatively understudied in the context of ND-CNV carriers, but recent studies indicate that it is an antecedent 35 of, and indexes, psychiatric disorder 36 in ND-CNV carriers. Our teacher-report measures confirmed that neuropsychiatric impairments were present in multiple settings, indicating pervasiveness. Our findings of broad ranging impairments is consistent with studies of common polygenic risk 37 and familial risk 38, 39 of psychiatric disorder, that find that genetic risk is associated with disrupted childhood neurodevelopment across several domains.
Strikingly, the specific effect of CNV genotype only accounted for 5-20% of variation in outcome depending on phenotypic trait, indicating that the majority of variance is explained by additional factors. We found that age was a predictor of outcome for several traits, both ADHD symptoms and . CC-BY 4.0 International license It is made available under a (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
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We also found that gender predicts outcome for ADHD related traits, however the effect sizes were small with gender accounting for <5% of the explained variance. A lack of strong gender differences in neurodevelopmental traits may reflect that male-to-female ratios for conditions such as autism are reduced in populations with intellectual disability 41 . Further research will be required to understand what genetic and environmental factors underlie the remaining, unexplained variation, in outcome.
The high prevalence of psychiatric disorders and the finding that ND-CNV carriers were impaired across all the cognitive, motor and psychopathological measures assessed highlight that children with ND-CNVs require coordinated multidisciplinary care to address a range of psychiatric, psychological, motor coordination, sleep and social and educational needs. This warrants a step change in current clinical service provision, and calls for greater awareness of this new patient group amongst clinicians and educators. The commonalities we are finding in clinical outcomes across all ND-CNVs suggest this group could benefit from the development of a general intervention plan, which could be expanded to include specific recommendations for more genotype-specific outcomes. Support and intervention plans for children with a ND-CNV eed to o sider the hild's eha iour i edu atio al a d peer contexts as well as address behaviour exhibited in the home or clinic. The broad ranging phenotypic outcomes associated with ND-CNVs indicates that genotype-phenotype relationships have a complex architecture. Current research efforts that use genetic first approaches in human studies and animal models as a way of identifying direct causal pathways from genotype to psychiatric disorder via intermediary phenotypes need to take account of these complexities, the use of an endophenotype approach should be cautioned 42 . Systems biology and network approaches are needed to globally capture the architecture of genotype-phenotype relationships. Efforts focusing on single causal pathways are likely to only provide limited research and clinical benefit.
.
Limitations
Individuals had to have a known genetic diagnosis to take part, the study would therefore not capture asymptomatic individuals who carry ND-CNVs. Therefore, the true phenotype in the general population is likely to be less severe than what we report, with bias being greater for those ND-CNVs with a lower penetrance. However, it is important to put our study in context with wider research.
Large population-based studies have examined the phenotype of ND-CNVs in adults from the general population 7, 9 , but the present study gives unique insights into the development of children at the more severe end of the phenotypic spectrum who are most likely to engage with health services and be in need of clinical and educational support. Some of our findings could reflect ascertainment bias, in that carriers with severe developmental delay are more likely to be referred to medical genetic clinics for testing. However, we found that the differences between ND-CNV carriers and controls remained significant after controlling for IQ.
Conclusion
Our findings provide evidence of specific genotype-phenotype relationships within CNV carriers both in terms of quantitative and qualitative differences. However, although differences can be identified, these account for a low proportion of variance and therefore we conclude that different genotypes do not result in discrete forms of neurodevelopmental disorders. Our dimensional approach facilitated the investigation of genotype-phenotype relationships beyond categorical psychiatric diagnosis. Using a multi-informant deep phenotyping approach we found that genomic risk for psychiatric disorder had wide ranging effects on childhood development spanning a range of cognitive and behavioural domains. Our findings highlight that there are core neurodevelopmental traits that are strongly impaired across all ND-CNV carriers, but additionally ND-CNV carriers are also affected by there are broad-ranging mental health and cognitive comorbidities. This suggests that multiple processes and neural circuits are affected by ND-CNVS. Future research into the relationship between genotype and psychiatric outcomes via intermediary endophenotypes needs . CC-BY 4.0 International license It is made available under a (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint . http://dx.doi.org/10.1101/535708 doi: bioRxiv preprint first posted online Jan. 31, 2019; to consider this when interpreting findings. Early detection of children with ND-CNVs is warranted to a) investigate antecedents and developmental course of neuropsychiatric impairments, b) add to the understanding of how genomic risk manifests, c) inform early intervention programs.
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